|1.||Suchocki, Piotr: 6 articles (12/2015 - 10/2007)|
|2.||Mosiniewicz-Szablewska, Ewa: 3 articles (12/2015 - 01/2012)|
|3.||Muehlmann, Luis Alexandre: 2 articles (12/2015 - 01/2014)|
|4.||de Souza, Ludmilla Regina: 2 articles (12/2015 - 01/2014)|
|5.||Azevedo, Ricardo Bentes: 2 articles (12/2015 - 01/2014)|
|6.||Simón-Vázquez, Rosana: 2 articles (12/2015 - 01/2014)|
|7.||González-Fernández, África: 2 articles (12/2015 - 01/2014)|
|8.||Morais, Paulo César: 2 articles (12/2015 - 01/2014)|
|9.||Báo, Sônia Nair: 2 articles (12/2015 - 01/2014)|
|10.||Anuszewska, Elżbieta: 2 articles (02/2015 - 01/2014)|
02/01/2015 - "The aim of the present study is the evaluation of Selol's influence on intracellular redox state (Eh) of prostatic tumors and the liver in androgen-dependent hPCa-bearing mice, and extracellular redox state in serum of these mice. "
01/01/2014 - "In this study, we assessed the effect of 5% Selol and DOX on the expression of genes that affect cell proliferation in the resistant KB-V1 and sensitive HeLa cell lines, using RT2 ProfilerTM PCR Array matrix "Human Cancer Drug Resistance and Metabolism" (SABiosciences). "
02/01/2015 - "After Selol treatment, intracellular Eh has increased in tumors from -223 mV to -175 mV, while in serum it has decreased (-82 mV vs -113 mV). "
01/01/2014 - "Both free Selol (S) and SPN reduced the viability of A549 cells, whereas S induced a greater reduction in non-tumor cell viability than SPN. "
01/01/2014 - "Selol, when used in KB-V1 cells, reduced the expression of MYC and BCL2 genes, suggested as a new therapeutic target in the treatment of cancers resistant to cytostatic drugs. "
|3.||Neuralgia (Stump Neuralgia)
11/01/2008 - "We examined the effect of the opioid receptor agonists and the effect of an antioxidant selol, which is an organoselenium compound on antinociceptive action of opioid agonists in diabetic neuropathic pain model. "
08/01/2008 - "Effect of organoselenium compound (selol), on antinociceptive action of opioid agonists in vincristine neuropathic pain model was investigated. "
11/01/2008 - "Effect of selol on the opioids activity in streptozotocin induced hyperalgesia."
08/01/2008 - "Effect of selenium compound (selol) on the opioid activity in vincristine induced hyperalgesia."
11/01/2008 - "Neither morphine, fentanyl nor buprenorphine administered alone in 7 consecutives days modified the STZ induced hyperalgesia, whereas selol slightly increased the nociceptive threshold. "
08/01/2008 - "Neither morphine, fentanyl nor buprenorphine administered alone in 5 consecutive days modified the vincristine-induced hyperalgesia, whereas selol slightly increased the nociceptive threshold. "
|5.||Prostatic Neoplasms (Prostate Cancer)
02/01/2015 - "Selol seems a promising compound for prostate cancer therapy. "
|2.||Morphine (MS Contin)
|9.||Opioid Receptors (Opioid Receptor)